<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74-pathogens-09-00083">
 <label>74.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jueliger</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lyons</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cannito</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pata</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Pata</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Shkolnaya</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lo Re</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Peyrou</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Villarroya</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Pazienza</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma</article-title>
  <source>Epigenetics</source>
  <year>2016</year>
  <volume>11</volume>
  <fpage>709</fpage>
  <lpage>720</lpage>
  <pub-id pub-id-type="doi">10.1080/15592294.2016.1214781</pub-id>
  <?supplied-pmid 27646854?>
  <pub-id pub-id-type="pmid">27646854</pub-id>
 </element-citation>
</ref>
